Yahoo
NasdaqCM - Delayed Quote USD

Pro-Dex, Inc. (PDEX)

58.16 -3.44 (-5.58%)
At close: October 30 at 4:00:00 PM EDT
Trade Pro-Dex on Coinbase
Chart Range Bar
Loading chart for PDEX
  • Previous Close 61.60
  • Open 65.65
  • Bid 50.00 x 1000
  • Ask 63.05 x 1100
  • Day's Range 58.00 - 65.65
  • 52 Week Range 28.81 - 77.00
  • Volume 38,474
  • Avg. Volume 63,729
  • Market Cap (intraday) 186.112M
  • Beta (5Y Monthly) 0.04
  • PE Ratio (TTM) 16.02
  • EPS (TTM) 3.63
  • Earnings Date Oct 29, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 74.00
  • Zacks Rating Bullish

Pro-Dex, Inc. designs, develops, manufactures, and repairs powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; manufactures and sells rotary air motors to various industries; and precision machined parts and assemblies for the aerospace and defense industries. Its products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

www.pro-dex.com

201

Full Time Employees

June 30

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PDEX
51.14%
S&P 500 (^GSPC)
10.73%

1-Year Return

PDEX
89.88%
S&P 500 (^GSPC)
11.11%

3-Year Return

PDEX
228.22%
S&P 500 (^GSPC)
81.91%

5-Year Return

PDEX
139.64%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY27
Revenue 20.56M
Earnings 3.05M
Profit Margin 14.82%

Q1

FY26

Q3

FY26

Q4

FY26

Q1

FY27

0
5M
10M
15M
20M
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%

Analyst Insights

View More

Analyst Price Targets

74.00
74.00 Average
58.16 Current
74.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/11/2026
Analyst Ascendiant Capital
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 70 -> 74

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.12%

  • Return on Assets (ttm)

    11.89%

  • Return on Equity (ttm)

    26.48%

  • Revenue (ttm)

    79.58M

  • Net Income Avi to Common (ttm)

    12.03M

  • Diluted EPS (ttm)

    3.63

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.99M

  • Total Debt/Equity (mrq)

    38.47%

  • Levered Free Cash Flow (ttm)

    8.25M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: